ストックスクリーナーアプリを入手
1.20
7.69%
-0.10
アフターアワーズ：
1.22
0.02
+1.67%
前日終値:
$1.30
開ける：
$1.31
24時間の取引高:
356.49K
Relative Volume:
0.69
時価総額：
$53.85M
収益：
$19.94M
当期純損益:
$-37.37M
株価収益率:
-1.1538
EPS:
-1.04
ネットキャッシュフロー:
$-33.38M
1週間 パフォーマンス:
-13.67%
1か月 パフォーマンス:
+10.09%
6か月 パフォーマンス:
-11.11%
1年 パフォーマンス:
-51.02%
1日の値動き範囲:
$1.20
$1.3386
1週間の範囲:
$1.20
$1.43
52週間の値動き範囲:
$0.595
$4.18
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
名前
Werewolf Therapeutics Inc
セクター
電話
617-952-0555
住所
200 TALCOTT AVENUE, WATERTOWN
HOWL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
1.20 | 60.58M | 19.94M | -37.37M | -33.38M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.16 | 118.34B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
554.58 | 60.31B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
339.80 | 42.35B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.89 | 36.43B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.94 | 31.87B | 3.81B | -644.79M | -669.77M | -6.24 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-04-03 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-08-24 | 開始されました | Wedbush | Outperform |
| 2023-06-06 | 再開されました | Jefferies | Buy |
| 2021-09-10 | 開始されました | BofA Securities | Buy |
| 2021-05-25 | 開始されました | Evercore ISI | Outperform |
| 2021-05-25 | 開始されました | H.C. Wainwright | Buy |
| 2021-05-25 | 開始されました | Jefferies | Buy |
| 2021-05-25 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Werewolf Therapeutics Inc (HOWL) 最新ニュース
Live market analysis of Werewolf Therapeutics Inc.Momentum Trading Guide with Safety Limits - Newser
Why Werewolf Therapeutics Inc. stock attracts strong analyst attentionTop Performing Stock Insights Released Daily - beatles.ru
Using data filters to optimize entry into Werewolf Therapeutics Inc.Long-Term Allocation Strategy Summary Breakdown - Newser
Will Werewolf Therapeutics Inc. stock benefit from AI tech trendsLong Term Stock Planner with Safety Checks - Newser
What makes Werewolf Therapeutics Inc. stock price move sharplyAnnual Market Behavior and Sector Summary - Newser
Why Werewolf Therapeutics Inc. is moving todayReal-Time Entry Signals for Top Stocks - Newser
Using economic indicators to assess Werewolf Therapeutics Inc. potentialPattern Recognition Tool for ROI Investors - Newser
Using Python tools to backtest Werewolf Therapeutics Inc. strategiesFree Swing Trading Entry Point Signals - Newser
Short interest data insights for Werewolf Therapeutics Inc.Stable Profit Zone and Loss Control Analysis - Newser
What earnings revisions data tells us about Werewolf Therapeutics Inc.Top Stock Picks with Forecast Accuracy - Newser
What machine learning models say about Werewolf Therapeutics Inc.Technical Insight Guide for Safer Trades - Newser
Key External Factors That Drive Werewolf Therapeutics Inc. Stock Price MovementsPrice Action Trading with Volume Confirmation - Newser
Published on: 2025-07-29 03:06:26 - metal.it
Screener Results Flag Werewolf Therapeutics Inc. as OversoldSector Based Breakout Stock Forecast Issued - metal.it
Should I hold or sell Werewolf Therapeutics Inc. stock in 2025Entry Signal Data Feed With Low Risk - jammulinksnews.com
What institutional investors are buying Werewolf Therapeutics Inc. stockPowerful profit generation - jammulinksnews.com
What are Werewolf Therapeutics Inc. company’s key revenue driversEntry Signal Data Feed With Low Risk - jammulinksnews.com
Live market analysis of Werewolf Therapeutics Inc. High Conviction Stock Long-Term Summary - Newser
What the charts say about Werewolf Therapeutics Inc. today Forecasting Stock Moves with AI Insights - Newser
How Resilient Is Werewolf Therapeutics Inc. Stock During Economic Downturns Swing Trade Timing with Daily Forecast - metal.it
How many analysts rate Werewolf Therapeutics Inc. as a “Buy”Build a portfolio that stands the test of time - jammulinksnews.com
When is Werewolf Therapeutics Inc. stock expected to show significant growthDynamic investment growth - jammulinksnews.com
How Werewolf Therapeutics Inc. stock performs during market volatility AI Swing Strategy Signal Forecasting System - Newser
What are the technical indicators suggesting about Werewolf Therapeutics Inc.Outstanding growth strategies - jammulinksnews.com
What catalysts could drive Werewolf Therapeutics Inc. stock higher in 2025High-impact investment strategies - jammulinksnews.com
How does Werewolf Therapeutics Inc. generate profit in a changing economyCapitalize on momentum-driven investment opportunities - jammulinksnews.com
What is the risk reward ratio of investing in Werewolf Therapeutics Inc. stockInvest smarter with daily market updates - jammulinksnews.com
Is Werewolf Therapeutics Inc. stock overvalued or undervaluedFree High-Return Strategy Alerts - jammulinksnews.com
How does Werewolf Therapeutics Inc. compare to its industry peersConsistent high-yield stocks - jammulinksnews.com
How Werewolf Therapeutics Inc. stock performs during market volatilityWatchlist Winner Update - Newser
What analysts say about Werewolf Therapeutics Inc. stockHigh-octane gains - PrintWeekIndia
Is Werewolf Therapeutics Inc. stock overhyped or has real potentialMarket-leading growth rates - jammulinksnews.com
Is Werewolf Therapeutics Inc. stock a growth or value playHigh-octane financial growth - jammulinksnews.com
Why Werewolf Therapeutics Inc. stock is on top investor watchlistsHigh-profit capital plays - jammulinksnews.com
What drives Werewolf Therapeutics Inc. stock priceSky-high return potential - Autocar Professional
Is Werewolf Therapeutics Inc. a good long term investmentRapidly growing investment returns - Autocar Professional
Werewolf Therapeutics Inc. Stock Analysis and ForecastSuperior stock selection - jammulinksnews.com
Werewolf Therapeutics Inc (HOWL) 財務データ
収益
当期純利益
現金流量
EPS
Werewolf Therapeutics Inc (HOWL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director |
May 14 '25 |
Buy |
0.98 |
162,539 |
159,288 |
6,237,482 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
May 13 '25 |
Buy |
0.98 |
52,974 |
51,915 |
6,074,943 |
| MPM BioVentures 2014, L.P. | 10% Owner |
Mar 27 '25 |
Sale |
1.05 |
1,963 |
2,061 |
3,208,793 |
| EVNIN LUKE | Director |
Mar 27 '25 |
Sale |
1.05 |
2,425 |
2,546 |
4,309,860 |
| GADICKE ANSBERT | 10% Owner |
Mar 27 '25 |
Sale |
1.05 |
4,386 |
4,605 |
6,718,670 |
0.23%
0.40%
大文字化:
|
ボリューム (24 時間):